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Reactive oxygen speciesIncrease of interstitial cell population, resulting in the expansion of interstitium, excessive production of extracel-
lular matrix, and reduction of functioning tubules, is critical in ﬁbrotic progression in the kidney of patients suffer-
ing from chronic renal diseases. Here, we investigated the contribution of bone marrow-derived cells (BMDC) in
kidney ﬁbrosis caused by ureteral obstruction (UO) using eGFP bone marrow-reconstituted chimeric mice. UO
caused dramatic increases in the numbers of interstitial cells and expansion of the interstitium.Most kidney inter-
stitial cells expressed GFP. Twenty nine percent of interstitial cells were cells that had proliferated and approxi-
mately 89% among them were BMDCs. Proliferation of ﬁbroblasts differentiated from BMDCs signiﬁcantly
occurred in the interstitiumofUO-kidney. Removal of BMDCsbywhole body irradiation after UO resulted in reduc-
tion of kidney ﬁbrosis, while injection of RAW264.7 cells, monocytes/macrophages, into irradiatedmice induced a
reversal of this reduction. Treatment with apocynin, an inhibitor of NADPH oxidase, reduced inﬁltration of BMDCs
into theUO-kidney, leading to reduction of kidney ﬁbrosis. In addition, only a few slow-cycling cellswere observed
in the interstitiumof normal kidney. Even after UO, no change in the number of those cells was observed. Our ﬁnd-
ings demonstrate that BMDCs are a major source for interstitial expansion during kidney ﬁbrosis via inﬁltration
into damaged sites, differentiation to ﬁbroblasts, and subsequent proliferation, contributing kidney ﬁbrosis.
These data provide a clear therapeutic target for treatment of chronic kidney disease.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Fibrosis is a common characteristic of chronic diseases in organs in-
cluding kidney [1,2]. In a healthy organ,ﬁbroblasts support parenchyma
via production of extracellular matrixes, and regulate interstitial ﬂuid
[3,4]. However, an excessive increase in number and activation of inter-
stitial cells in a ﬁbrotic kidney leads to production of excessive extracel-
lular matrix (ECM) protein and expansion of interstitial area, resulting
in tubular atrophy and loss of tubular function [1,4]. Therefore, it has
been suggested that control of the expansion of interstitial area is impor-
tant to treatment of kidney ﬁbrosis.
Inﬂammatory responses have classically been recognized as a main
contributor in progression of ﬁbrosis in many organs, including kidney,
liver, and lung [5–8]. Among them, accumulating evidence shows that
macrophages in particular have been regarded as a main contributor to
kidney ﬁbrosis; reduction of renal ﬁbrosis by depletion of macrophages
and inhibition of macrophage recruitment has been reported [9,10]. By
contrast, some studies have demonstrated an anti-ﬁbrotic role of inﬁl-
trating macrophages in kidney ﬁbrosis via phagocytosis [11]. Likewise,nd BK 21 Program, Kyungpook
ong, Junggu, Daegu, 700-422,
800.
rights reserved.although a clear role of bone marrow origin cells, including macro-
phages, in kidney ﬁbrosis has not been deﬁned, a vast number of stud-
ies have suggested that bone marrow-derived cells (BMDCs), including
ﬁbrocytes, T-cells, and macrophages, play an important role in kidney
ﬁbrosis induced by ureteral obstruction (UO) [1,5,12,13]. Supporting
this suggestion, Broekema et al. reported that 32% of myoﬁbroblasts
observed in ischemia and reperfusion-injured kidney were derived
from bone marrow (BM) [14]. Li et al. reported that more than 30% of
total myoﬁbroblasts originated from BM in adriamycin-induced intersti-
tial ﬁbrosis of kidney [15]. However, ﬁndings from several recent studies
showing involvement of other cells, including pericytes/perivascular
ﬁbroblasts, tubular epithelial cells, endothelial cells, and resident ﬁbro-
blasts, in progression of kidney ﬁbrosis [4] and lack of evidence showing
direct involvement of BMDCs in the expansion of interstitium have chal-
lenged the importance of BMDCs in kidney ﬁbrosis.
Therefore, in the present study, in order to determine the origins of
increases in interstitium in the ﬁbrotic kidney and the role of BMDCs in
kidney ﬁbrosis, we investigated the contribution of BMDCs and their
proliferative capacity in kidney ﬁbrosis induced by UO. Herein, we report
that an expansion in the area of interstitium caused by UO originated
predominantly fromBMDCs via inﬁltration into the damaged site, subse-
quent proliferation at the inﬁltrated site. By contrast, resident or stem/
progenitor cells localized in the interstitiummay not be primary contrib-
utors to the expansion in the area of interstitium during progression of
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and administration of inhibitor of reactive oxygen species (ROS) produc-
ing enzyme to reduce the number of BMDCs in the ﬁbrotic kidney
prevent kidney ﬁbrosis.
2. Materials and methods
2.1. Animal preparation
All experiments were conducted using 8 week-C57BL/6 male mice
weighing 20 to 25 g (Koatech, Gyounggido, Korea). eGFP-expressing
mice [C57BL/6-TgN(ACTbEGFP)10sb]were purchased from Jackson labo-
ratory. The studywas performed in accordancewith the guidelines of the
Institutional Animal Care and Use Committee of Kyungpook National
University. Unilateral ureteral obstructionwas induced as described pre-
viously [16]. In brief, body temperature was maintained at 36.5–37.5 °C.
Kidneys were exposed via ﬂank incision. The right ureter of mice was
obstructed completely near the renal pelvis using 6-0 nylon; the inci-
sions were then closed using an autoclip. Sham-operated mice were
subjected to the same surgical procedures, except for the ureter ligation.
Mice were harvested at 1, 3, and 12 days after UO. For detection of
proliferating cells or slow-cycling cells, mice were treated with BrdU
(50 mg/kg body weight; Sigma) from 2 days before the operation to
harvest or at postnatal 1 day to 3 days. Some mice were treated with
apocynin (10 mg/kg body weight, a putative NADPH oxidase inhibitor,
Calbiochem) from 1 h after the operation to the time of harvest. For
immunoﬂuorescence staining, PLP-ﬁxed kidneys were washed for
5 min, three times, with phosphate-buffered saline (PBS), embedded in
parafﬁn, and cut into 2-μm sections using amicrotome (RM2165; Leica).
2.2. Bone marrow transplantation
As described previously [17], we generated BM chimera with donor
bone marrow expressing enhanced GFP (eGFP). For donation of bone
marrow (BM), eGFP mice (8 to 10 weeks old) were anesthetized with
pentobarbital sodium (60 mg/kg body weight), followed by harvest of
BM from femurs and tibias of eGFP-mice. Recipient mice (8 weeks old)
were irradiated with 8 grays (Gy) using a cesium-137 source irradiator.
eGFP-expressed BM cells of 1 × 107 were injected into irradiated recipi-
ent mice via tail vein. BM transplanted mice were left to recover and to
reconstitute BM for 8 weeks before UO.When BMTwas failed, irradiated
mice started to die 6 days after irradiation.
2.3. Elimination of BM-derived cells and transfer ofmonocytes/macrophages
Normal mice were subjected to either UO or sham. Two days after
operation, mice were irradiated with 8 Gy, and then received 1 × 106
RAW264.7 cells or vehicle immediately after irradiation via the tail
vein. To track the cells, some mice were received 1 × 106 RAW264.7
cells labeledwith PKH26 (Sigma) immediately after irradiation. Chime-
ric mice with eGFP-BM were subjected to either UO or sham. Two days
after operation, mice were irradiated with 8 Gy. Kidneys were
harvested at 7 days after operation.
2.4. Immunoﬂuorescence staining
Immunoﬂuorescence stainingwas performed as described previously
[18]. Antibodies used were: GFP (Santa Cruz), FSP-1 (Novus), collagen III
(Abcam), α-SMA (Sigma), PCNA (Cell Signaling), F4/80 (gifted from
Dr. Bonventre JV, Harvard University), and BrdU (Serotec). Sections
were observed under an LSM 5 confocal microscope (Carl Zeiss), an
Axioplan-2 epiﬂuorescence microscope (Carl Zeiss) or Nikon Fx35
(Nikon). To identify interstitial cells, kidney sections were visualized
under V-2A ﬂuorescence ﬁlter, which can distinguish both kidney
morphology and DAPI-stained nuclei. Numbers of interstitial cells
were determined by counting DAPI-positive cells in the interstitium.Numbers of GFP-, FSP-1, and BrdU-positive and interstitial cells were
determined in 10 high-power ﬁelds per kidney.2.5. Measurement of collagen III deposition and α-SMA expression
Kidney sections were immunostained using anti-collagen III and
α-SMAantibodies. Collagen III andα-SMAexpressing areawas calculated
using i-solution software (iMTechnology) and averaged in 10high-power
ﬁelds per kidney.2.6. Electron microscopic immunocytochemistry
Fifty-micrometer vibratome sections were processed for immunocy-
tochemistry using an indirect preembedding immunoperoxidasemethod,
as described previously [19]. All sections were washed three times with
50 mM NH4Cl in PBS for 15 min. Prior to incubation with the primary
antibody, the sections were pretreated with a graded series of ethanol,
followed by incubation for 3 h with PBS containing 1% bovine serum
albumin (BSA), 0.05% saponin, and 0.2% gelatin (solution A). The tissue
sectionswere then incubated overnight at 4 °Cwith the antibody against
GFP (Santa Cruz Biotechnology, Santa Cruz, CA) diluted in 1% BSA-PBS
(solution B). Control incubations were performed in solution B without
primary antibody. After several washes with solution A, the sections
were incubated for 2 h in peroxidase-conjugated donkey anti-goat lgG
Fab fragment (Jackson ImmunoResearch laboratories, West Grove, PA)
diluted in solution B. The tissues were rinsed ﬁrst in solution A and
subsequently in 0.05 M Tris buffer (pH 7.6). For detection of horseradish
peroxidase, sections were incubated in 0.1% 3,3′-diaminobenzidine in
0.05 M Tris buffer for 5 min; H2O2 was then added to a ﬁnal concentra-
tion of 0.01% and the incubation was continued for 10 min. After wash-
ing with 0.05 M Tris buffer, the sections were dehydrated in a graded
series of ethanol. Kidney sections were embedded in poly/Bed-812
resin (Polysciences,Warrington, CA) between polyethylene vinyl sheets,
excised, and glued onto empty blocks of poly/Bed-812 resin. Following
examination of 1 μm semithin sections by light microscopy, ultrathin
sections were cut, stained with uranyl acetate, and photographed using
a transmission electron microscope, JEOL 1200EX (Tokyo, Japan).2.7. Western blot
Western blot analyses were performed as described previously [16].
Antibodies usedwere: GFP (Santa Cruz), collagen I (Santa Cruz),α-SMA
(Sigma), PCNA (Sigma), and GAPDH (Santa Cruz). LabWork software
was used for quantiﬁcation of band densities.2.8. FACS analysis
Apreviously describedmethodwas used for harvest of bonemarrow
from femurs and tibias of transgenic EGFP mice [17]. Ammonium chlo-
ride, potassium (ACK) lysis buffer was used for removal of residual
erythrocytes. Bone marrow was washed in PBS, then ﬁxed with 1%
PFA, prior to analysis to determine the proportion of cells with green
ﬂuorescence. Using an FACS analyzer (BD FACSCalibur™ ﬂow
cytometer, BD bioscience), we observed that eGFP BM reconstituted to
BM of irradiated recipient mice.2.9. Statistics
Results were expressed as the means ± SEM. Statistical differences
among groups were calculated using Student's t-test. Each experimental
group consisted of at least three mice. Differences between groups were
considered statistically signiﬁcant at a p value of b0.05.
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Fig. 1. Population of BMDCs and BM-derived FSP-1+ ﬁbroblasts in kidney interstitial cells after UO. eGFP BM-chimeric mouse kidneys were subjected to either UO or sham-
operation, followed by harvest at 1, 3, and 12 days after the operation. (A) Parafﬁn-embedded kidney sections were immunostained with anti-GFP (green) and -FSP-1 (red) anti-
bodies. DAPI was used for detection of nuclei (blue). Pictures were taken of the cortex in the kidney. Numbers of interstitial cells were counted under V-2A ﬂuorescence ﬁlter, which
can visualize both cell morphology and DAPI-stained nuclei. Numbers of interstitial GFP+ (B) and FSP-1+ (D) cells and their percent (C, E) to the total number of interstitial cells
was determined in 10 high-power ﬁelds per kidney (n = 4–5 per group). Interstitial cell number was evaluated using nucleus staining with DAPI. (F) % of GFP+ cells in FSP-1+ cells.
Scale bar, 20 μm. Values indicate means ± SEM; *P b 0.05 vs. sham.
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3.1. BMDCs are a major contributor to the increased number of interstitial
ﬁbroblasts in the ﬁbrotic kidney
To quantify the number of BMDCs in the interstitium of UO-kidney,
we performed transplantation of eGFP-BM into normal C57BL/6 mice
to generate eGFP-expressing bone marrow (BM) chimeric mice [17].F
Sham
DC
BA
Fig. 2. Fibroblast-characteristics of BMDCs in UO-induced ﬁbrotic kidneys. BM-chimeric mi
(A-D) One μm semithin kidney sections (A, B) were cut, stained with uranyl acetate, and photog
in fusiform ﬁbroblast-like cells (arrows) in the interstitial spaces of the UO kidney (n = 3per grou
processes between striated collagen ﬁbrils (arrowheads). Insets are high magniﬁcation images ofWe performed FACS analysis to conﬁrm reconstitution of eGFP-BM;
about 95% BM of normal mice were reconstituted by eGFP-expressing
cells (Suppl. 1). After UO, the total number of interstitial cells showed a
dramatic increase over time (Fig. 1A and B). GFP-positive (GFP+) cells
accounted for most of the interstitial cells (31.8 ± 1.0% at 1 day;
65.5 ± 2.0% at 3 days; 83.5 ± 0.8% at 12 days after UO) (Fig 1C). To
examine the question of whether GFP+ cells in the interstitium possess
the features of ﬁbroblasts, kidney sections were double-stained withF
UO
ce were subjected to either UO or sham, followed by harvest at 12 days after the operation.
raphed using a transmission electron microscope (C, D). GFP immunostaining was observed
p). GFP+ cells showed typical characteristics of ﬁbroblasts (marked as “F”)with long tapering
the rectangle. Scale bar, 5 μm.
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recently it has been reported that FSP-1 expresses in macrophage, FSP-1
is widely used and is a well-known marker for ﬁbroblasts in several
tissues, including kidney [2,20]. The process for retrieval of epitopes in
double immunoﬂuorescence staining caused the original GFP signal to
fade out; therefore, we used anti-GFP antibody for detection of the GFP
signal. We conﬁrmed detection of most of eGFP-expressing cells by the
anti-GFP antibody (Suppl. 2). The number of FSP-1-positive (FSP-1+)
cells showed a gradual increase in the interstitium over time (Fig. 1A
and D). Among interstitial cells, 17.8, 60.5, and 55.8% were FSP-1+ cells
at 1, 3, and 12 days after UO, respectively (Fig. 1E). More than 90% of
FSP-1+ cells were GFP+ cells at 12 days after UO (Fig. 1F), indicating
that BMDCs are a major contributor to increases in the number of inter-
stitial cells in UO-kidneys and some of BMDCs may differentiate to
ﬁbroblasts.
Further, to identify the characteristics of GFP+ cells, we performed
1 μm semithin-section immunostaining (Fig. 2A and B) and electronmi-
croscopic study (Fig. 2C andD). GFP+ cells observed in the interstitiumof
UO-kidneys showed typical characteristics of ﬁbroblasts and producedA
B
C
Fig. 3. Expression of ﬁbrosis-related proteins in UO-induced ﬁbrotic kidneys. BM-chimeric m
the operation. (A) Expression of GFP, α-SMA, collagen I, and PCNA was evaluated by Weste
Parafﬁn-sectioned kidney was immunostained with anti-GFP (green), -α-SMA (red), and -co
or GFP and collagen III. Nuclei were detected using DAPI (blue). % expression areas were
means ± SEM; *P b 0.05 vs. sham.collagen ﬁbers (Fig. 2B and D). FSP-1+ cells showed a spindle-shaped
morphology (Fig. 1A), a typical phenotype of ﬁbroblasts. These morpho-
logical data suggest that some of GFP+ cells in the interstitium of
UO-kidneys may be functional ﬁbroblasts. Next, we performed Western
blot analysis to determine the levels of GFP protein and other ﬁbrosis-
related proteins. Amount of GFP protein was greater in UO-induced
ﬁbrotic kidney than in sham-kidney (Fig. 3A). Signiﬁcant elevation of
α-SMA (Fig. 3A and B), collagen I (Fig. 3A), PCNA (Fig. 3A), and collagen
III (Fig. 3C) expression was observed in UO-induced ﬁbrotic kidney.
Taken together these results indicate that BMDCs are main contributor
in the interstitial expansion, leading to kidney ﬁbrosis.
3.2. BMDCs proliferate in the interstititum of UO-kidney
To examine the question ofwhether or not the continuous increase in
the population of interstitial BMDCs was a result of either continuous
inﬁltration of BMDCs into the interstitium or proliferation of inﬁltrated
BMDCs that were differentiated or non-differentiated to ﬁbroblasts, we
determined proliferating cells during the entire period of UO. Brieﬂy,ice were subjected to either UO or sham, followed by harvest at 1, 3, and 12 days after
rn blot analysis. GAPDH was used as an equal loading marker (n = 3 per group). (B, C)
llagen III (red) antibodies. Arrowhead indicates double-positive cells to GFP and α-SMA
determined in 10 high-power ﬁelds per kidney (n = 4–5 per group). Values indicate
821H.-S. Jang et al. / Biochimica et Biophysica Acta 1832 (2013) 817–825BrdU, a thymine analog, was injected daily into mice from 2 days
before UO until harvest of kidney. BrdU incorporation reveals prolif-
erating cells due to incorporation of BrdU into DNA during S phase of
the cell cycle [21]. BrdU-positive (BrdU+) cells showed a gradual
increase in the interstitium of UO-kidney over time (Fig. 4A and D). Six,
26, and 29% of interstitial cells were BrdU+ cells at 1, 3, and 12 days
after UO, respectively (Fig. 4E). Double positive cells against both anti-
GFP and -BrdU antibodies continuously increased over time (Fig. 4).
We observed dividing GFP+ cells in the interstitium (Fig. 4C). Results
of triple staining using anti-GFP, -FSP-1, and -BrdU antibodies showed
that 44.4% and 45.1% of interstitial BrdU+ cells were GFP+/FSP+ and
GFP+/FSP− cells, respectively (Fig. 4B and F); approximately 90% of
cells in the proliferating interstitial cell population in UO-kidney were
BMDCs (Fig. 4B and 4G). However, only 0.5% of cells in BrdU+ interstitial
cells in UO-kidney were GFP−/FSP+ cells (Fig. 4G). These results indicate
a signiﬁcant number of BMDCs in the interstitium, whereas a very small
number of non-BM derived cells, proliferate in ﬁbrotic kidney.
3.3. Removal of BMDCs by irradiation and inhibition of BMDC inﬁltration
by apocynin treatment attenuate UO-induced kidney ﬁbrosis
After UO, monocytes/macrophages, which were F4/80-positive
(F4/80+) cells, greatly increased in the interstitium of the kidney
(Fig. 5A). To investigatewhether reduction of F4/80+ cells via inhibition
of BMDCs generation in BM can prevent kidney ﬁbrosis, normal mice
were subjected to whole body irradiation 2 days after UO. Irradiation
induced a signiﬁcant reduction in the number of F4/80+ cells in the
interstitium (Fig. 5A), α-SMA expression (Fig. 5A to C), and collagen
deposition (Fig. 5A and D) in UO-kidneys. In eGFP-BM chimeric mice,A B
D E F
Fig. 4. Phenotypes of proliferating cells in the interstitium of UO-induced ﬁbrotic kidney. BM
12 days after the operation. Mice were treated with BrdU from 2 days before the operation
and -BrdU (red) antibodies. DAPI (blue) was used for detection of nuclei. Pictures were tak
triple immunostained with anti-GFP (green), -FSP-1 (red), and -BrdU (blue) antibodies. (C)
DAPI (blue)was used for detection of nuclei. Numbers (D) and percentages (E) of BrdU+ cells of in
bers (F) andpercentages (G) ofGFP+/FSP+/BrdU+,GFP+/FSP−/BrdU+,GFP−/FSP+/BrdU+, andGF
per kidney (n = 3 per group). Arrowhead, double positive cells of GFP and BrdU; arrow, triple p
tubules. Values indicate means ± SEM; *, P b 0.05 vs. sham.8 Gy irradiation induced at 2 days after UO also signiﬁcantly inhibited
the increase of GFP+ cells in the interstitium (Fig. 5E to F). Injection
of RAW264.7 cells, mouse monocytes/macrophages, into irradiated
mice induced a reversal of the reduction in numbers of F4/80+ cells
(Fig. 5A), α-SMA expression (Fig. 5A to C), and collagen deposition
(Fig. 5A and D). We observed PKH26-labeled RAW264.7 cells in the
kidney (Suppl. 3), indicating inﬁltration of injected RAW264.7 cells
into the UO-kidney.
A number of studies have demonstrated that oxidative stress causes
inﬁltration of inﬂammatory cells into the kidneys and that antioxidant
treatment inhibits inﬁltration of leukocytes in ﬁbrotic kidneys [22–25].
Therefore, to determine whether inhibition of inﬁltration of BMDCs by
inhibition of ROS production can prevent kidney ﬁbrosis, we treated
mice with apocynin, an inhibitor of NADPH oxidase, a major generator
of superoxide. Apocynin is well-known as an inhibitor of NADPH oxidase
2 by blockage of translocation of p47phox, resulting in the reduction of
superoxide formation by NADPH oxidase 2 [26–28]. Treatment with
apocynin resulted in signiﬁcantly reduced inﬁltration of BMDCs (Fig. 6A
and B) and numbers of FSP+ cells (Fig. 6A and C) and BrdU+ cells
(Fig. 6D and E). In addition, treatment with apocynin resulted in reduced
expression ofα-SMA (Fig. 6F andG) and deposition of collagen III (Fig. 6H
and I). These results support the role of BMDCs as a major contributor in
kidney ﬁbrosis.
3.4. Fate of slow-cycling cells in kidney ﬁbrosis
Recent studies have demonstrated that kidneys possess stem-/
progenitor-like cells (stem cells). However, their role in kidney ﬁbrosis
is largely unknown. To investigate roles of renal stem cells in kidneyC
G
-chimeric mice were subjected to either UO or sham, followed by harvest at 1, 3, and
to the time of harvest. (A) Sections were double immunostained with anti-GFP (green)
en of the cortex in the kidney. (B) Sections of kidney harvested 12 days after UO were
Sections were double immunostained with anti-GFP (green) and -PCNA (red) antibodies.
terstitial cells were determined in 10 high-power ﬁelds per kidney (n = 3per group). Num-
P−/FSP−/BrdU+of interstitial cells inﬁbrotic kidneyweredetermined in10high-powerﬁelds
ositive cells of GFP, FSP-1, and BrdU. Scale bar, 20 μm. Dotted lines indicate the outer line of
A B
D
C
E F
Fig. 5. Prevention of kidney ﬁbrosis by irradiation to inhibit production of BMDCs. normal (A to D) or eGFP-BM-reconstituted mice (E to F) were subjected to either UO or sham and
irradiated 2 days after UO, followed by harvest of kidneys at 7 days after the operation. Some normal mice received 1 × 106 of RAW264.7 cells via tail vein immediately after ir-
radiation. Parafﬁn-sectioned kidney was immunostained with anti-F4/80 (A, green), α-SMA (A, green), and GFP (E, green) antibodies. DAPI (blue) was used for detection of nuclei.
(A) α-SMA expression and collagen deposition were shown in green by immunostaining and blue by Masson trichrome staining, respectively. Pictures were taken of the cortex in
the ﬁbrotic kidney by UO. (B) Western blot analysis was performed using anti-α-SMA and -GAPDH as an equal loading marker, antibodies. Bands from Western blot analysis were
representative of three individual experiments; density was evaluated using LabWork software. Areas of α-SMA-expression (C) and collagen deposition (D) were evaluated using
i-Solution software. Areas of α-SMA expression and collagen deposition were determined in 10 high-power ﬁelds per kidney (n = 3 per group). (E) Pictures were taken of the
cortex in the ﬁbrotic kidney after UO. (F) Number of GFP+ cells was determined in 10 high-power ﬁelds per kidney (n = 3 per group). Arrowhead, F4/80+ cell. Scale bar,
50 μm. Values indicate means ± SEM; *, P b 0.05 vs. sham; †, P b 0.05 vs. irradiated mice with UO.
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into neonatal mice, as previously described [29–31]. BrdU-retaining
slow-cycling cells were mainly localized in tubular epithelial cells, and
were only occasionally observed in the interstitial area of non-UO kidneys
(Fig. 7 and Suppl. 4). No signiﬁcant changewas observed in the number of
BrdU-positive cells in the interstitium after UO (Fig. 7), indicating that in-
terstitial slow-cycling cells did not proliferate afterUO. AfterUO, thenum-
ber of BrdU+ cells in kidney tubules showed a gradual decrease over time
(Fig. 7), indicating that BrdU-labeled tubular epithelial cells had either di-
vided or died [29–31].
4. Discussion
Expansion of the interstitial area followed by increases in the num-
ber of interstitial cells and production of extracellular matrix proteins
is a typical characteristic of kidney ﬁbrosis. Findings from our present
study demonstrate that 1) BMDCs inﬁltrate into the interstitium of
UO-kidneys and occupy a major portion of the interstitial cell popula-
tion, resulting in expansion of the interstitium, 2) proliferation of
BMDCs occurs at the inﬁltrated site, 3) treatment with irradiation
and ROS producer inhibitor to reduce the inﬁltration of BMDCs into
the interstitium attenuates kidney ﬁbrosis, 4) deletion of monocyte/macrophage reduces kidney ﬁbrosis, and 5) label-retaining slow-cell cy-
cling cell located in the interstitium hardly contribute to increases in the
number of interstitial cells. All of these ﬁndings support that BMDCs are
the main contributor to increase of interstitial cells in UO-kidney, leading
to expansion of the interstitial area and progression of ﬁbrosis, suggesting
that inhibition of inﬁltration of BMDCs is a good strategy for treatment of
kidney ﬁbrosis.
In the present study, we evaluated the proportion of BMDCs and
its involvement in UO-induced kidney ﬁbrosis. Most of the interstitial
cells observed in UO-kidneywere BMDCs (83.5% at 12 days UO), indicat-
ing that BMDCs are a major contributor to expansion of the interstitium.
Twelve days afterUO, 55%of interstitial cellswere FSP-1+ cells and93.5%
of FSP-1+ cells were GFP+ cells, indicating that most interstitial cells
originated from BMDCs. The rest, approximately 6% of interstitial cells,
may have originated from other sources, including resident ﬁbroblasts,
dendritic cells, pericytes, tubular epithelial cells, and endothelial cells.
This ﬁnding suggests that differentiation followed by recruitment of
BM-origin cells is of critical importance and that BMDCs are a major
portion of interstitial cells in UO-induced kidney ﬁbrosis. Supporting
these ﬁndings, semithin-section immunostaining and electron mi-
croscopic data showed that GFP+ cells are spindle-shaped ﬁbroblasts
with collagen ﬁbrils, which express collagen III, indicating that GFP+
AD
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Fig. 6. Inhibition of kidney ﬁbrosis by administration of antioxidant, apocynin. BM-chimeric mice were subjected to either UO or sham, followed by harvest at 12 days after the
operation. Some mice were administered intraperitoneally with apocynin (10 mg/kg body weight, Calbiochem) or vehicle (10% DMSO) beginning at 1 h after operation until
harvest, daily. For detection of proliferating cells, mice received BrdU from 2 days before the operation to the time of harvest. Parafﬁn-sectioned kidney was immunostained
with anti-GFP (green, A) and -FSP-1 (red, A), -BrdU (red, D), -α-SMA (red, F), and collagen III (red, H) antibodies. DAPI (blue) was used for detection of nuclei. (A) Double
positive cells of GFP and FSP-1 were shown by a yellow color. Pictures were taken of the cortex. (D) Arrows and arrowheads indicated tubular and interstitial BrdU+ cells,
respectively. Numbers of interstitial GFP+ (B), FSP-1+ (C), BrdU+ cells (E), and expressing areas of α-SMA (G) and collagen III (I) were determined in 10 high-power ﬁelds
per kidney (n = 3 per group). Scale bar, 20 μm. Dotted lines indicate the outer line of tubules. Values indicate means ± SEM; *, P b 0.05 vs. respective sham; †, P b 0.05 vs.
respective vehicle-treated.
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recent studies reported that FSP-1 is expressed in several cell types and
semi-thin and EM morphological data are not direct evidences for
transdifferentiation of GFP+ cells to ﬁbroblasts, further studies are re-
quired for proving transdifferentiation of GFP+ cells to ﬁbroblasts.
Inﬁltration of cells derived from peripheral blood mononuclear cells
or CD14-positive monocytes of BM into injured sites, contributing to
pathological ﬁbrosis has been reported [32–34]. Cells derived from
monocytes showed spindle-shaped features [35]. Mori et al. reported
that 61.4% of ﬁbrocytes isolated from wounds expressed myoﬁbroblast
marker, α-SMA, and originated primarily from BM [36]. In peripheral
blood of patients with chronic obstructive asthma, ﬁbrocytes showed
an eight-fold increase, compared with patients with non-obstructive
asthma; the cells were active ﬁbroblasts expressing myoﬁbroblast
marker [37]. Findings from a number of studies have demonstrated inﬁl-
tration of monocyte-derived ﬁbrocyte precursor into the interstitium of
damaged kidneys, differentiation into ﬁbroblasts, and activation of ECM
production by TGF-β [33,38,39].
Next,we attempted to determinewhether the gradual increase in the
population of BMDCs in the interstitium after UO was due to prolifera-
tion of BMDCs at the inﬁltrated site or continuing inﬁltration of BMDCs
into the interstitium via BrdU-labeling of proliferating cells. Results
showed that 6, 26, and 29% of interstitial cells were BrdU+ cells at 1, 3,
and 12 days after UO, respectively. Surprisingly, 89.5% of BrdU+ cells
were GFP+ at 12 days after UO; 44.4% among BrdU+ cells were FSP-1+
cells and the rest, 45.1%, were BrdU- and FSP-1+ cells. These resultsindicate that an increase in the number of BMDCs in the interstitium is
due to proliferation of inﬁltrated BMDCs. Approximately 10.4% of inter-
stitial proliferating cells did not originate from BM, and 0.5% among
them was FSP+ cells. From this study, we know that proliferation of
BMDCs that may be differentiated and non-differentiated in the
interstitium contributes signiﬁcantly to increases in the interstitial cell
population. Also, it may be possible that circulating GFP-positive BMDCs
with BrdU label inﬁltrate into interstitial area in the kidney after UO.
Further, we performed testing to determine whether removal of
BMDCs can inhibit kidney ﬁbrosis. Irradiation, a simple and reliable
method for elimination of BMDCs [40], inhibited increases in inﬁltration
of BMDCs, collagen deposition, and α-SMA expression in UO-kidneys.
However, reconstitution of macrophages by injection of RAW264.7
cells into irradiated mice restored severity of kidney ﬁbrosis following
UO, suggesting that BMDCs are detrimental in progression of kidney
ﬁbrosis. A number of studies have demonstrated that inﬁltration
of BMDCs into injured sites triggers initiation of pathogenesis, pro-
motes a pathological situation, and sustains chronic dysfunction of organs
[1,6,8,18,41]. Lin et al. demonstrated the ﬁbrogenic capacity ofmonocyte-
derivedmacrophages originated from BM, but not residentmacrophages,
inUO-induced kidneyﬁbrosis [42]. Kitagawa and colleagues reported that
gene deletion or inhibitor of CCL2, which is expressed by most macro-
phages, resulted in blockade of macrophage inﬁltration into kidney
interstitium and amelioration of kidney ﬁbrosis by UO [12]. In previous
studywe found that 8 Gy irradiationwhich is same amount of irradiation
used in present study did not induce signiﬁcant changes of renal functions
No
. o
f B
rd
U+
ce
lls
0.0
0.2
0.4
0.6
0.8
1.0
1.2
UOSham
UOSham
GFP/BrdU/DAPI
Fig. 7. Interstitial slow-cycling cells in UO-induced kidney ﬁbrosis. Pups were treated with BrdU at postnatal 1 day to 3 days, chased to 8 weeks, and then reconstituted to GFP-BM
after irradiation. BM-chimeric mice were subjected to either UO or sham, followed by harvest at 1, 3, and 12 days after the operation. Parafﬁn-sectioned kidney was immunostained
with anti-GFP (green) and -BrdU (red) antibodies. DAPI (blue) was used for detection of nuclei. Pictures were taken of the cortex in the kidney at 12 days after sham-operation or
UO. Numbers of interstitial BrdU+ cells were determined in 10 high-power ﬁelds per kidney (n = 3 per group). Arrow, interstitial BrdU+ cell. Scale bar, 20 μm. Dotted lines indicate
the outer line of tubules. Values indicate means ± SEM.
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induce signiﬁcant fate change of resident cells including macrophages
or other cell types. However, we did not completely rule out effects of
irradiation on resident cells.
Although it remains unclear role of polarization of monocytes/
macrophages in kidney ﬁbrosis, many studies have demonstrated that
polarization of monocytes/macrophages involves in kidney ﬁbrosis.
Some studies have demonstrated that monocyte/M1 macrophage
[42,44,45] and M2 macrophage [46] induce kidney ﬁbrosis. On the
other hand, there are reports that polarization to M2 reduces kidney
ﬁbrosis [45,47]. In an experiment model of acute kidney tubular ne-
crosis, Ferenbach and colleagues also suggested that phenotype of
monocytes/macrophages is important to decide the fate of ischemia/
reperfusion-injured kidney [48]. Therefore, we speculate that regulation
of inﬁltrated BMDCs polarization may be important in the progression
of ﬁbrosis. Further studies to classify the phenotype of inﬁltrated BM-
derivedmonocytes/macrophages may provide fruitful information to de-
ﬁne the role of bonemarrow-derivedmonocytes/macrophages in kidney
ﬁbrosis.
Antioxidants mitigate both inﬂammation and oxidative stress
[22,24,49]. Suppression of ROS generation and improvement of the
ROS scavenging system also results in reduction of kidney ﬁbrosis,
along with decreased inﬂammation and oxidative stress [22,23]. Recent-
ly, we and others have demonstrated that antioxidant supplements
inhibit kidney ﬁbrosis via decrease of renal interstitial NADPH oxidase 2
(Nox2, a primary generator of ROS) expression, oxidative stress, and inﬁl-
tration of leukocytes into the interstitium [23,24,49,50]. Nox2 is expressed
primarily in BMDCs during progressive kidney ﬁbrosis [25]. Apocynin has
been shown to prevent kidney ﬁbrosis and inﬂammation in an animal
model with hypertension and diabetic nephropathy, suggesting a rela-
tionship between kidney ﬁbrosis and BMDC inﬁltration, as well as the
effect of apocynin in inhibition of ROS generation [23,24]. In the present
study,we found that treatmentwith apocynin to inhibit BMDC inﬁltration
reduces the number of ﬁbroblasts and deposition of collagen III in
UO-kidneys. These results of irradiation and apocynin treatment indicate
that BMDCs, particularly monocyte-derived cells with ﬁbrogenic proper-
ties, are critical to progression of ﬁbrosis.
Finally, to investigate involvement of intrarenal stem cells in kidney
ﬁbrosis, we attempted to determine whether those cells proliferate
during progression of kidney ﬁbrosis. We labeled cells with BrdU in
order to detect slow-cycling cells, which have been used for detection
of stem cells [29–31], and then tracked the fate of BrdU-labeled cells.
After 121 day of chase phase, BrdU+ cells were detected, but were
very rare in the kidney interstitium of adult mice subjected to a sham-
operation. After UO, the number of BrdU+ cells in the interstitium did
not differ from those of sham. This ﬁnding indicates that proliferationof label-retaining slow-cycling cells in the interstitiumhardly contribute
to kidney ﬁbrosis. In addition, since we occasionally found FSP-1+ cells
in the tubular epithelium, it is likely that BrdU+ cells in the tubules
that disappeared might have rarely become ﬁbroblasts by the EMT pro-
cess after UO.
Because recent studies have reported that FSP-1 is expressed in
several types of cells and semi-thin and EM morphological data may
not be direct evidences of transdifferentiation of GFP+ cells to ﬁbro-
blasts, here, we could not clearly conclude that BMDCs differentiate
to functional ﬁbroblasts. However, our ﬁndings from the present
study demonstrate that BMDCs are a major contributor to expansion
of the interstitial area via inﬁltration and subsequent proliferation,
resulting in reduction of functional nephrons. These data provide a
clear therapeutic target for treatment of chronic kidney disease, such as
ﬁbrosis.
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